LVZ Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73M Sell
1,441
-92
-6% -$94K 0.18% 41
2026
Q1
$1.41M Buy
1,533
+23
+2% +$23.3K 0.16% 41
2025
Q4
$1.62M Buy
1,510
+77
+5% +$73.6K 0.18% 43
2025
Q3
$1.09M Buy
1,433
+336
+31% +$250K 0.12% 53
2025
Q2
$855K Buy
1,097
+5
+0.5% +$3.88K 0.1% 62
2025
Q1
$902K Buy
1,092
+81
+8% +$67.4K 0.12% 53
2024
Q4
$780K Buy
1,011
+107
+12% +$88.6K 0.1% 56
2024
Q3
$801K Buy
904
+84
+10% +$75.5K 0.1% 54
2024
Q2
$742K Sell
820
-10
-1% -$8K 0.1% 54
2024
Q1
$646K Sell
830
-5
-0.6% -$3.56K 0.09% 57
2023
Q4
$487K Buy
835
+288
+53% +$168K 0.07% 70
2023
Q3
$294K Sell
547
-46
-8% -$23.7K 0.05% 85
2023
Q2
$278K Sell
593
-20
-3% -$8.39K 0.04% 116
2023
Q1
$211K Buy
613
+18
+3% +$6.07K 0.03% 135
2022
Q4
$218K Buy
+595
New +$211K 0.03% 132

Other funds holding LLY

LVZ Inc's LLY Position: Q2 2026 in Review

LVZ Inc reduced its Eli Lilly (LLY) stake by 6% in Q2 2026, selling an estimated $94K and leaving 1,441 shares worth $1.73M. The position accounts for 0.18% of the portfolio, ranked #41.

LVZ Inc first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LVZ Inc held 1,441 shares of Eli Lilly worth $1.73M as of Q2 2026.
  • LVZ Inc sold 92 Eli Lilly shares in Q2 2026, an estimated $94K.
  • Eli Lilly made up 0.18% of LVZ Inc's portfolio in Q2 2026, its #41 holding.
  • LVZ Inc first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LVZ Inc's 13F filing for Q2 2026, filed 9 Jul 2026.